CIK: 1055947 - Address: 44 Montgomery St., 40Th Floor, San Francisco, CA 94104
27 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
10/31/24 17:53
10/29/24
THRDThird Harmonic Bio, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCAHSee ExplS-14,30014.300-1,000-85177D
10/8/24 18:50
10/4/24
MLTXMoonlake ImmunotherapeuticsDEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADTS.d-100,00350.000-2,000-611,288D
5/13/24 17:04
5/9/24
ELDNEledon Pharmaceuticals, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP.d00.0001,928220D
12/20/23 18:09
12/18/23
PNTPoint Biopharma Global Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCAHFormer 1S-213,65812.450-17,161-1000D
11/17/23 16:54
11/15/23
RPTXRepare Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP.m6,2505.0901,227549D
11/6/23 18:07
11/2/23
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.dm5,30112.800414295D
11/3/23 17:37
11/2/23
RPTXRepare Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP2,8213.600784485D
9/14/23 16:25
9/12/23
OLMAOlema Pharmaceuticals, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTP.d14,8189.8401,506624M
5/9/23 20:25
5/5/23
ELDNEledon Pharmaceuticals, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP.d00.0001,979145D
1/13/23 17:08
1/11/23
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.dm1,25130.5104122,146D
1/9/23 17:44
1/5/23
XOMAXoma CorpDEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTHSee RemaP.dm42118.9102212,056D
12/22/22 18:49
12/20/22
THRDThird Harmonic Bio, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP8794.110214786241D
11/10/22 18:31
11/8/22
RAINRain Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADTHSee ExplP.d9,9715.8301,710893,630D
9/27/22 19:22
9/23/22
XOMAXoma CorpDEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTHSee RemaP.dm40916.6102512,038D
9/16/22 18:30
9/14/22
XOMAXoma CorpDEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTHSee RemaP.dm99117.5905632,211D
8/23/22 17:35
8/22/22
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.d14,18426.000546258D
8/11/22 17:52
8/9/22
CTICCti Biopharma CorpDEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTHSee RemaS.d-52,0206.120-8,500-792,272M
6/15/22 18:15
6/13/22
RPTXRepare Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP1,89912.73014957413D
6/14/22 16:46
6/10/22
OLMAOlema Pharmaceuticals, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCADTP.d8074.03020063,378D
6/6/22 18:14
6/2/22
RPTXRepare Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP.m21,85911.9001,837406D
6/3/22 18:24
6/1/22
CGEMCullinan Oncology, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP8,26511.000751364D
5/31/22 19:50
5/26/22
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.dm4,15014.340289231D
5/24/22 20:09
5/20/22
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.d14114.000105217D
5/20/22 18:09
5/18/22
RPTXRepare Therapeutics Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP3,5708.500420313D
5/16/22 19:34
5/12/22
CGEMCullinan Oncology, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP.m10,0649.0701,110319D
5/9/22 19:20
5/5/22
KYMRKymera Therapeutics, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/IlCADHSee RemaP.dm4,86519.460250217D
4/5/22 18:45
4/1/22
CGEMCullinan Oncology, Inc.DEFinancInvAdvInvestment AdviceBvf Partners L P/ilCATP2,96710.750276122,498D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact